Harmonization of large-scale, heterogeneous individual participant adverse event data from randomized trials of statin therapy
<p><strong>Background:</strong> Meta-analyses of individual-level data from randomized trials are often required to detect clinically worthwhile effects. The Cholesterol Treatment Trialists’ Collaboration, which includes data from numerous large long-term statin trials, is conduct...
Main Authors: | Emberson, J, Spata, E, Blackwell, L, Davies, K, Halls, H, Harper, C, Roddick, A, Samuel, N, Stevens, W, Wallendszus, K, Preiss, D, Collins, R, Baigent, C, Reith, C |
---|---|
Other Authors: | Cholesterol Treatment Trialists’ Collaboration |
Format: | Journal article |
Language: | English |
Published: |
SAGE Publications
2022
|
Similar Items
-
Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials
by: Reith, C, et al.
Published: (2022) -
Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis
by: Reith, CA, et al.
Published: (2024) -
Efficacy and safety of statin therapy in older people: meta-analysis of individual participant data from 28 randomised controlled trials
by: Cholesterol Treatment Trialists' Collaboration, et al.
Published: (2019) -
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
by: Cholesterol Treatment Trialists' Collaboration, et al.
Published: (2016) -
Angiotensin receptor blockers and β-blockers in Marfan syndrome: an individual-patient-data meta-analysis of randomised trials
by: Pitcher, A, et al.
Published: (2022)